Progress in the treatment of Pneumocystis pneumonia

Pneumocystis pneumonia (PCP) is a pulmonary disease that occurs frequently in immunocompromised and acquired human immunodeficiency virus infected patients.Severe patients can be life-threatening.Trimethoprim-sulfamethoxazole is the first choice for first-line treatment, but it has potential drug resistance.Most mild patients have good prognosis after using compound sulfamethoxazole and active treatment of primary diseases.However, for severe patients, due to lack of specific diagnostic methods in the early stage, the course of disease progresses rapidly, and glucocorticoid therapy can be combined to reduce the mortality of PCP.This article reviews the progress of treatment of PCP. Key words: Pneumonia; Homones; Sulfamethoxazole; Spores